Results 81 to 90 of about 653 (147)

Pathogen Reduction of Transfused Blood Components-The End of the Beginning Rather than the Beginning of the End. [PDF]

Pathogens
Farrugia A, Corash L, Goodrich R, von Bonsdorff L.   +3 more
europepmc   +1 more source

Impact of buffy coat reduction on the severity of febrile nonhemolytic transfusion reactions with red cell components. [PDF]

Asian J Transfus Sci, 2023
Singh L, Prinja N, Jain A, Sharma RR, Marwaha N.   +4 more
europepmc   +1 more source

Haemovigilance.

JPMA. The Journal of the Pakistan Medical Association, 2013
Farheen, Karim, Natasha, Ali, Salman Naseem, Adil   +2 more
openaire   +1 more source

Platelet component safety in the era of new advancements in bacterial screening and pathogen reduction: A congress report of the 2024 ISBT Transfusion-Transmitted Infectious Diseases Working Party, Bacteria Subgroup. [PDF]

Vox Sang
García-Otálora MA, McDonald C, Bearne J, Brown B, Cheng A, Humbrecht C, Tiberghien P, Ramirez-Arcos S, ISBT Transfusion‐Transmitted Infectious Diseases Working Party Subgroup on Bacteria.   +8 more
europepmc   +1 more source

Bridging the Gap: Promoting Adverse Drug Reaction Reporting through Innovative Strategies in Zero-reporting Zones at Karaikal - An Educational Intervention Study at Adverse Drug Reaction Monitoring Center. [PDF]

J Res Pharm Pract
Palanisamy PR, Kiruthika S, Ravichandran D.   +2 more
europepmc   +1 more source

The Australian and New Zealand Massive Transfusion Registry: An innovation focusing on data collection, standardisation and interoperability between healthcare systems. [PDF]

Health Inf Manag
Sparrow RL, Haysom HE, Loh JB, Caithness K, Mandapaka K, Wellard C, McQuilten ZK, Wood EM.   +7 more
europepmc   +1 more source

Low burden of clinically relevant anaemia and thrombocytopenia among adolescents living with HIV receiving tenofovir/lamivudine plus dolutegravir: the CIPHER-ADOLA study in Cameroon. [PDF]

AIDS Res Ther
Fainguem NN, Bouba Y, Kamgaing R, Gabisa JE, Ka'e AC, Tchouaket MCT, Nka AD, Ayafor C, Forgwei L, Kamgaing N, Tetang SN, Ateba FN, Takou D, Tameza DG, Noukayo F, Ketchaji A, Jagni Semengue EN, Roland WB, Agabus W, Gnambi AR, Eyenga C, Etame NK, Kengni Ngueko AM, Moko Fotso LG, Yimga JF, Zam KN, Motaze AN, Chenwi CA, Beloumou GA, Djupsa Njdeyep SC, Roy U, Ajeh RA, Njom Nlend AE, Koki PN, Tchidjou HK, Armenia D, Santoro MM, Ceccherini-Silberstein F, Sosso SM, Ndjolo A, Colizzi V, Perno CF, Fokam J.   +42 more
europepmc   +1 more source

Transfusion risks and haemovigilance [PDF]

ISBT Science Series, 2020
openaire   +1 more source

Review of haemovigilance at the Rabat Regional Blood Transfusion Centre in Morocco (2017-2021). [PDF]

Pan Afr Med J
Lemssahli I, Benajiba M, Belmekki A.
europepmc   +1 more source